Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.5%

3 terminated out of 40 trials

Success Rate

84.2%

-2.3% vs benchmark

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed with results

Key Signals

5 with results84% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (7)
Early P 1 (2)
P 1 (3)
P 2 (13)
P 3 (3)
P 4 (1)

Trial Status

Completed16
Unknown12
Not Yet Recruiting5
Terminated3
Recruiting2
Active Not Recruiting1

Trial Success Rate

84.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (40)

Showing 20 of 20 trials
NCT06747949Phase 3RecruitingPrimary

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

NCT05946941Phase 3Active Not RecruitingPrimary

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

NCT06544642Phase 1Terminated

A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

NCT07244289Unknown

Managed Access Programs for VAY736, Ianalumab

NCT07414667Not Yet RecruitingPrimary

Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)

NCT07118241Phase 2RecruitingPrimary

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE

NCT07212322Not ApplicableNot Yet Recruiting

A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

NCT07290946Phase 2Not Yet Recruiting

Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors

NCT04572841Phase 2CompletedPrimary

Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)

NCT07192666Early Phase 1Not Yet RecruitingPrimary

Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome

NCT07185139Early Phase 1Not Yet RecruitingPrimary

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

NCT04129164Phase 2CompletedPrimary

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

NCT05605665Phase 1CompletedPrimary

Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome

NCT05680064Not ApplicableCompletedPrimary

The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome

NCT02833311Not ApplicableCompleted

e-Mobile Tablet for People With Chronic Conditions

NCT04747288UnknownPrimary

Objective Measurement With TCM Pattern for AIDDES

NCT05633524CompletedPrimary

HRR as a Novel Biomarker in Sjögren's Syndrome

NCT04798911CompletedPrimary

SS-INQ Information Needs Questionnaire in Sjögren's Syndrome

NCT03937271WithdrawnPrimary

Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome

NCT03983408Not ApplicableUnknownPrimary

Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease

Scroll to load more

Research Network

Activity Timeline